The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Chloe Childress, a counselor at Camp Mystic, died during the flooding in Hunt, Texas, according to a representative of her high school....
Explore the limits of tolerance and faith in the face of tragedy and societal issues....
loading...